PAPER B Flashcards
wad is the 1 year prevalence of depression in general population
5.3%
Life time prevalence of depression in general population
13%
highest risk age group for depression
greater than 30`
mean onset of depression
30 years
Mean number of episodes in patients with lifetime MDD is
5
what is the longest duration of a depressive episode if treated, usually will last how many months
24 weeks (6 months) 3 months
Mean age of treatment for depression
33.5 (lag 3 years for depression)
Most common comorbidity with depression
alcohol use (>40%) and anxiety (40%) second is personality disorder 30% (mostly cluster C except anakanistic PD)
% of depressive patient made suicide attempt
how many more times more a patient will attempt to commit suicide compared to normal population
9%
14 times
% of person with first episode of depression will have mania episode within 10 years and its risk factors (5)
10%,
if illness earlier, switch was earlier (rate is 50%)
family history, antidepressant induced hypomania, hypersomnia, retarded phenomenology, psychotic depression and postpartum episode
Mean age of unipolar to bipolar switch
average number of previous episode before the switch
32
2-4 episode
what is the longest duration of a depressive episode
if untreated
if untreated 6-13 months
recurrence rate of first episode
% of ppl will not have anymore episode, the rest will have within how long
% did not have a year free of episode
50% will not have any further episode, thr erest wil have it within 5 years
15% will not have a year free of episode
hows bipolar patient’s episode when compared to depression
2 times more
Terms for depression
1) remission
2) recover
3) relapse
4) recurrence
1) when patient achieved a state where no scales can detect meaningful measures of depression after 3 months of a treated episode
2) if the above more than 6 months
3) any repeat depression within 6 months
4) any depressive episode after 6 months of the initial episode
good prognostic indicators for depression (7)
1) mild episode
2) <1 episode of hospital admision
3) no psychotic symptoms
4) short hospital stay
5) history of solid friendship during adolescence
6) stable family functioning
7) no comorbid psychiatric disorder
8) good social functioning 5 years before illness
bad prognostic indicators for depression (7)
1) severity episode (suicidality and psychotic features)
2) persistent dysthymia
3) female sex
4) long previous episode
5) nvr marrying
6) long episode of illnes before seeking treatment
7) comorbid psychiatric and medical disorder
8) greater number of prior episode (3 or more)
9) partial remission at 3 months
NICE gudeline, points for management
1) first classify severity of the depresion
2) if there’s depression and anxiety, treat depression well
3) mild depression, review withnin 2 weeks, no need meds, can do CBT
4) SSRI first line
5) of moderate, to keep antidepressant for 6 months
6) if >2 episodes, need to keep for >2 years
7) if atypical use SSRI, then refer specialist
what study studies the continuation of antidepressants
Gedds and colleagues
include 410 patients
31 randomised trails
rate of relapse for 41% for those who stop antidepressant after an acute episode compared to 15%
wad is STAR*D
- similar world findings - 2/3 has comorbid physical disorder, 2/3 comorbid psych diagnosis, 40% has onset depression <18 years
- 4041 patient enrolled
- step 1 citalopram-> step 2 after 12 weeks to swucth to (buporion, sertaline, venlafaxine, or cognitive therapy or augment citalopram + buporion/buspirone, or citalopram with cognitive therapy
- step 3 switch to mirtazapine/nortriptyline, or augment step 2 treatment with lithium/thyroid medication
- step 4 MAOI, tranylcypromine, venla +mirta
- remission rates drop while relapse rate increases as patient to each level
results
-switch to class withnin SSRi is no diff then switch to outside SSRI
-no stat diff betwen switch options, or augment options , maoi with venla+ mirtaz
cumulative remission rate is 67%
gender diff with depression
Men report more suicidal ideation, 2-4 times more likely to be successful in their suicidal attempts, ,psychomotor agitation and substance use.
Women reported more suicidal attempts , more symptoms of anxiety and atypical depression, earlier onset, trend towards longer episodes
antidepressant -> increase suicide risk?
more in younger age group 18-24
Healy study shows in general suicide risk is 1.64 times
2015 study shows that antidepressany is not associated with increased risk of completed suicide
three antidepressant drugs that shows greater toxicity
TCA : dosulepin and doxepine more toxic than venlafaxine and mirtazapine more toxic than SSRI: citalopram
Wad are 5 things that might result in apparent resistance to antidepressant treatment (not true resistance)
5A
alcoholism, lack of adequate dosage, lack of adherance, axis 2 disorder, alternate diagnosis